Ardent Health Inc (NYSE: ARDT) Financial Overview and Analyst Forecast

Font: Financial Modeling Prep  • Nov 15, 2025

• Whit Mayo from Leerink Partners sets a price target of $16 for ARDT, indicating a potential increase of approximately 77.58%.
• Ardent Health reports a quarterly loss of 17 cents per share, missing analyst expectations.
• Despite the earnings miss, quarterly sales reached $1.577 billion, with significant growth in revenue and adjusted EBITDA by 9% and 46%, respectively.

Ardent Health Inc (NYSE: ARDT) is a healthcare company that operates hospitals and healthcare facilities across the United States. The company provides a range of services, including inpatient and outpatient care, surgery, and emergency services. Ardent Health competes with other healthcare providers like HCA Healthcare and Tenet Healthcare.

On November 14, 2025, Whit Mayo from Leerink Partners set a price target of $16 for ARDT. At the time, the stock was priced at $9.01, suggesting a potential increase of approximately 77.58%. This optimistic outlook comes despite Ardent Health's recent financial challenges.

Ardent Health reported disappointing earnings for the third quarter, with a quarterly loss of 17 cents per share. This was below the analyst consensus estimate of a 41-cent profit per share. Consequently, the company reduced its FY2025 GAAP EPS guidance from $1.73-$2.01 to $0.85-$1.03.

Despite the earnings miss, Ardent Health's quarterly sales reached $1.577 billion, surpassing the expected $1.547 billion. Marty Bonick, President and CEO, highlighted positive trends, including a 5.8% increase in admissions and a 2.9% rise in adjusted admissions. Total surgeries also increased by 1.4%.

Revenue and adjusted EBITDA saw significant growth, increasing by 9% and 46%, respectively. The current stock price of $9.01 reflects a decrease of 3.12% or $0.29. Over the past year, ARDT has fluctuated between a high of $17.91 and a low of $8.85, with a market capitalization of approximately $1.29 billion.